Blue Water Life Science Advisors, LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 9 US equity positions worth $159.3m in its Q4 2025 13F filing. The largest position was GH at 22.8% of the reported book, followed by NTRA and ADPT. Against the Q3 2025 filing, it opened 2 new positions, added to 2 and reduced 2 among the top 9 holdings.
What did Blue Water Life Science Advisors, LP own in Q4 2025? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 22.8% | $36.3m | 355,047 | -12% | reduced |
| 2 | NTRA NATERA INC | Healthcare | 20.3% | $32.4m | 141,494 | 0% | held |
| 3 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 18.0% | $28.7m | 1,765,145 | -18% | reduced |
| 4 | PSNL PERSONALIS INC | Healthcare | 8.4% | $13.3m | 1,676,300 | 0% | held |
| 5 | QTRX QUANTERIX CORP | Healthcare | 8.4% | $13.3m | 2,092,147 | 118% | added |
| 6 | TWST TWIST BIOSCIENCE CORP | Healthcare | 7.6% | $12.1m | 383,000 | – | new |
| 7 | CDNA CAREDX INC | Healthcare | 6.0% | $9.6m | 510,000 | 0% | held |
| 8 | GRAL GRAIL INC | 5.3% | $8.5m | 99,000 | – | new | |
| 9 | TEM TEMPUS AI INC | Healthcare | 3.2% | $5.1m | 86,412 | 19% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.